The IL-lR, on EC was apparently functional, since EC responded to IL-1 with IL-6 mRNA expression and IL-6 bioactivity production. These results were extended to human EC and vascular smooth muscle cells, which were also found to express mRNAfor IL-lR,.
marrow granulocytes.21 These cells do not express the
Little is known concerning the IL-lR present on EC. Thieme et al' characterized the binding of IL-la to human umbilical vein ECs. By immunoprecipitation and chemical cross-linking to the ligand they identified a 78 Kd IL-1-binding protein on human EC. 24 Here we report that vascular cells (mouse EC; human EC, and smooth muscle cells [SMC] ) express the 80 Kd IL-lR,.
IL-lR,.
MATERIALS AND METHODS

Cells.
The mouse endothelioma cell lines sEnd.1 and tEnd.1 were obtained through the courtesy of Dr E.F. Wagner (European Molecular Biology Laboratory, Heidelberg, FRG). These cell lines, derived from a subcutaneous (s) and thymic (t) hemangioma, express the polyoma middle T antigen, have cobblestone endothelial-like morphology, express von Willebrand factor, and cause hemangiomas in vivo.25**6 Expression of von Willebrand factor was checked during this study. The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 15% fetal bovine serum (FBS) and 750 pg/mL G418. Human ECs were isolated from umbilical veins and cultured in medium 199 (GIBCO, Paisley, Scotland) supplemented with 20% FBS in the presence of an EC cell growth supplement (50 @mL; Sigma Chemical Co, St Louis, MO) and porcine intestinal heparin (100 pg/mL; Sigma). EC were used within the eighth passage.
Human vascular SMCs derived from the femoral artery were kindly donated by Dr G. Gabbiani (University of Geneva School of Medicine, Switzerland). SMC were cultured in DMEM containing 10% FBS. When cells were confluent, human recombinant IL-1p (Sclavo, Siena, Italy) was added at 10 ng/mL for 4 or 20 hours before extraction of mRNA. IL-lp had a specific activity of 1 X l@ U/p,g on D10.G4.1 cells when compared with the interim IL-lp reference reagent 86/552 (arbitrary titer 1 X l@ Ulpg; NBSB, NIBSC, Potters Bar, South Mimms, UK) and was free of endotoxin Human recombinant IL-la, radioiodinated with the chloramine T method, was purchased from Du Pont-NEN (Boston, MA) and had a specific activity of 2.2 x lo6 dpdpmol. Endothelioma cells were grown to confluency on 8-chamber tissue culture chambedslides (Lab-Tek Division, Miles Laboratories, Naperville, IL). Washed monolayers were incubated with approximately 0.3 nmol/L ' "I IL-la in 0.1 mL of DMEM with 15% FBS and 0.02% NaN, (binding medium) for 3 hours at room temperature with gentle agitation. At the end of the incubation, gaskets were removed, slides were extensively washed (I 0.08 pg LPS/p,g IL-1).
Autoradiographic determination of IL-1 binding. ' The cut off for positivity of IG1 binding was calculated as the median number of silver grains on cells incubated with cold IG1 plus three times the standard deviation (SD), multiplied for a field factor (ie, the number of grains per field without cells in the slides incubated with labeled IL-lP divided by that in slides incubated with cold IL-lB).
Replicate confluent monolayers of 1 to 2 X 106 cells per well of Cluster6 plates (Costar, Cambridge, MA) were incubated with increasing doses of '=I IL-1 in 0.5 mL of binding medium for 3 hours at room temperature under gentle agitation on a rocking platform. Nonspecific binding was assessed in the presence of a 500-fold molar excess of unlabeled IL-1. Wells were then extensively washed in PBS, monolayers were dissolved in 0.5 mL 9.5 m o m urea, and radioactivity was counted. Control monolayers were trypsinized for exact determination of cell numbers. Calculations and Scatchard analysis were performed according to Munson and Rodbard?' Affinity cross-linking. '=I IL-la was cross-linked to intact cells with disuccinimidyl suberate (DSS) or with dithiobis (disuccinimidyl propionate) (DSP) (Pierce, Rockville, MD) as previously described.16 Briefly, cell monolayers (3.0 x lo7 cells) in binding medium were incubated with IL-la (0.5 nmoUL) for 3 hours at room temperature in gentle agitation with or without a 500-fold molar excess of unlabeled IL-1. After washing the unbound IL-1, DSS or DSP (50 mg/mL in DMSO) were added to a final concentration of 2 mg/mL, and the reaction was allowed to proceed for 45 minutes at room temperature with vigorous shaking, then centrifuged in Eppendorf for 5 minutes. The supernatant was denatured with Laemmli sample buffer?' Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was run on 10% gel using colored molecular weight markers (Amersham, Little Chalfont, UK). Dried gels were exposed at -40°C using Kodak XAR-5 autoradiographic film.
Northern blot analysis was performed according to standard procedures.30 Total RNA was isolated from confluent cell cultures by guanidine isothiocyanate method." In some instances, polyadenylated RNA was prepared by chromatography on oligo dT cellulose columns (Pharmacia, Uppsala, Sweden). Aliquots of 10 pg total RNA were analyzed by electrophoresis through 1% agarose formaldehyde gels followed by Northern blot transfer to Gene Screen Plus membrane (Du Pont-NEN). A human IL-1 receptor cDNA (HindIII-EcoRI fragment of 477 bp)" was obtained through the courtesy of Dr S.K. Dower The mouse IL-6 cDNA probe (EcoRI-BglII fragment of 650 bp) was a kind gift of Dr J. Van Snick (Ludwig Institute, Bruxelles, Belgium). These fragments were labeled to a specific activity of lo9 cpm/pg by using hexanucleotide primers and a3*P-CTP. Membranes were pretreated and hybridized in 50% formamide (Merck, Rahaway, NJ) with 10% dextran sulfate (Sigma) and washed twice with 2x SSC (lx SSC: 0.15 moUL sodium chloride, 0.015 m o m sodium citrate) then twice with 2x SSC plus 1% SDS (Merck) at 60°C for 30 minutes and finally twice with 0 . 1~ SSC at room temperature for 30 minutes.
The membranes were exposed for 12 to 24 hours at -80°C with intensifying screens. RNA loading and transfer to membrane was ZL-1 binding assay.
Northern blot analysis.
checked by examination under UV light and hybridization of the blot with an a-actin probe.
ZL-6 bioactiviry assay. IL-6 was measured as hybridoma growth factor (HGF) activity using the 7TD1 cell line, obtained through the courtesy of Dr J. Van Snick. Briefly, 2 x 10' cells in 200 pL (four replicates per experimental point) were cultured for 72 hours with different dilutions of the supernatants to be tested or of the appropriate control medium. Routinely, cell proliferation was assessed by the (3-4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetra- zolium bromide colorimetric test as described." Alternatively, cells were pulsed with 0.5 kCi/well ['HI dThd (sp act 185 GBq/mmol; Amersham) for 6 hours. HGF activity resulting in half maximal stimulation of target cell growth was arbitrarily defined as 1 U. Reference standards used in these experiments consisted of human recombinant IG6 or IL-brich supernatant of a mixed lymphocyte reaction.
RESULTS AND DISCUSSION
Vascular cells are one important target for IL-1. On interaction with IL-1, ECs undergo a complex reprogramming of function, which favors thrombosis, leukocyte recruitment, and inflammation? A limitation to the detailed analysis of modulation of EC functions has been the unavailability of continuous EC lines. Recently, murine endothelioma cells lines have been established from hemangiomas developed in mice on infection with a retroviral vector carrying the polyoma virus middle T oncogene.".26 These lines have endothelial morphology and express EC markers," and might thus be suitable for study of E C modulation in vitro, if they also maintain EC functional characteristics. In order to evaluate the ability of polyomatransformed cells to respond to IL-1 modulation, two of these lines, sEnd.1 and tEnd.1, have been analyzed for expression of IL-lR and functional response to IL-1 stimulation. We focused on mouse EC initially because most available information concerning the existence of differential distribution of distinct IL-1R has been obtained in the The characteristics of the IL-1R present on endothelioma lines have been assessed by binding studies. As shown in Fig 2 (A,B) , the two endothelioma lines tEnd.1 and sEnd.1 showed specific and saturable binding of radioiodinated human recombinant IL-la. The number of IL-1 binding sites per cell and the affinity of binding were similar between the two lines (1,273 sites per cell with kd 9.5 X lo-" mol/L for sEnd.1, and 771 sites per cell with kd 8.5 X lo-'' mol/L for tEnd.1, respectively). IL-1 receptors on human EC showed similar characteristics (ref. 23 and 35; 2 experiments not shown), with a somewhat lower number of binding sites (100 to 500 sites per cell). By chemical cross-linking of radiolabeled IL-la to sEnd.1 membrane proteins with DSS, a single cross-linking product could be seen, of molecular weight of approximately 98 Kd (Fig 2,  C) . Accordingly, the presence of a 98 Kd product was evident also when DSP was used as a cross-linking agent (data not shown). By subtracting the molecular weight of bound IL-la (17.5 Kd), this corresponded to an IL-1 binding protein of approximately 80 Kd. This is in agreement with the molecular weight of the IL-lR described on human EC (ie, 78 Kd)" and suggests that the IL-1R expressed by EC is the IL-lR,. To clarify this point, the expression of mRNA encoding the IL-lR, has been examined. As shown in Fig 3, both sEnd.1 and tEnd.1 had appreciable levels of IL-lR, transcripts, though these were substantially lower than those detected in 3T3 murine fibroblasts used as positive controls (these express over 5,000 IL-lR per cell).21s36
Having established that the mouse endothelial lines express IL-lR,, it was important to evaluate whether these cells indeed respond to IL-1 stimulation, ie, whether their IL-1R was functional. As shown in Fig 4, IL-1 was able to induce high levels of IL-6 mRNA in both the sEnd.1 and the tEnd.1 lines. In parallel to detection of message transcription for IL-6, an increase of IL-6 biologic activity could be detected in the culture supernatant. In fact, IL-1-stimulated sEnd.1 and tEnd.1 cells produced 568 U/mL and 1,250 U/mL of IL-6, respectively, whereas only 82 U/mL and 83 U/mL of IL-6 bioactivity could be detected Exposure of human vascular cells, as well as murine endothelioma cells, to IG1 did not appreciably affect IL-lR, mRNA expression (Fig 5, data not shown) .
The results reported here demonstrate that murine EC and human EC and SMC express IL-lR,, though they do not formally exclude that these cells may at the same time have other IL-1R types on their membrane.
The availability of the recently cloned soluble form of IL-lR:9 and that of a neutralizing monoclonal antibodies for the murine IL-lR,Z' will help to finely evaluate in vitro and in vivo the precise role of IL-1 in vascular cell activation in pathologic conditions.
